SYS-CON MEDIA Authors: Jason Bloomberg, Kevin Benedict, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

In-depth Research on China Animal Vaccine Industry, 2014

DUBLIN, April 17, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/kwvsk6/indepth_research) has announced the addition of the "In-depth Research on China Animal Vaccine Industry, 2014" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

At present, there are 88 animal vaccine manufacturers in China, with 338 production lines. But most of enterprises are small in scale, vaccine production inspection is not standard and product structures are not reasonable. Market shares are occupied by a minority of enterprises.

According to the statistics by China Veterinary Drug Association (CVDA), the production capacity of live vaccines was 344.58 billion doses in 2012; the production capacity of inactivated vaccines was 55.392 billion milliliters; in China's animal vaccine industry, the annual sales revenue reached CNY 8.888 billion in 2012, and the top 10 enterprises as for sales revenue accounted for 50% of total sales revenue of biological products.

Among the key animal vaccine manufacturers in China in 2012, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the most business income registering CNY 1.17 billion, accounting for 13.16% market share. TECON, Dahuanong, Jinyu Group and Ringpu also had more than 5% market share respectively.

According to the report, the growth of China's animal vaccine market was slowing down in 2013, it was estimated that year-on-year growth was about 15% and the market scale reached CNY 10.22 billion in 2013, of which, swine vaccine accounted for 50% shares and poultry vaccine accounted for 36%.

Key Topics Covered

1. Development Environment of China's Animal Vaccine Industry
1.1 Market Characteristics
1.2 Economic Environment
1.3 Policy Environment

2. Technology Development of China's Animal Vaccine Industry
2.1 Product Technology Maturity
2.2 Technology Gap between China and Foreign Countries and Main Reasons
2.3 Strategy for Improving China's Technology

3. Development of China's Animal Vaccine Industry
3.1 Swine Vaccine
3.2 Poultry Vaccines
3.3 Pet Vaccines

4. Economic Operation of Animal Vaccine Industry
4.1 Industry Production and Sales in 2012
4.2 Industry Scale, 2008-2013
4.3 Industry Profit in 2012
4.4 Industry Profitability in 2012
4.5 Industry Business Development Capacity in 2012
4.6 Industry Debt Paying Ability in 2012

5. Import and Export of China's Animal Vaccine
5.1 Import
5.2 Export

6. Effect of Industry Competition Landscape on Investment in China, 2013
6.1 Porter Five Forces Analysis of China's Animal Vaccine Industry
6.2 Competition Landscape of China's Animal Vaccine Industry
6.3 Competition Forecast of China's Animal Vaccine Industry

7. Domestic Key Enterprises, 2013

8. Investment Analysis of Animal Vaccine Industry, 2014-2018
8.1 Investment Opportunity
8.2 Investment Risk
8.3 Industry Barriers to Entry
8.4 Industry Investment Proposals

9. Investment Opportunity and Risk of Animal Vaccine Industry
9.1 Investment Opportunity of China's Animal Vaccine Industry
9.2 Investment Efficiency of Animal Vaccine Industry

Companies Mentioned

  • Chengdu TECBOND Biological Products
  • China Animal Husbandry Industry (CAHIC)
  • Guangdong Dahuanong Animal Health Products
  • Inner Mongolia Jinyu Group Stock
  • Qingdao Yebio Bioengineering
  • TECON
  • Tianjin Ringpu Bio-technology 

For more information visit http://www.researchandmarkets.com/research/kwvsk6/indepth_research

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.